Sign in

CIK 0001653087 · Accelerated filer<br>Smaller reporting company

Alector, Inc.

Sign in to watch
Ticker
ALEC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
822933343
Phone
415-231-5660
Business address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
Former names
Alector LLC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market sale Chief Medical Officer sold 10,000 shares at $22.27 ($222,700)
  5. 4 Open-market sale 10% owner sold 85,414 shares at an average $23.53 ($2,009,559)
  6. 4 Open-market sale 10% owner sold 379,885 shares at an average $23.74 ($9,019,571)
  7. 4 Open-market sale 10% owner sold 250,000 shares at $24.50 ($6,125,000)
  8. 4 Open-market sale 10% owner sold 138,653 shares at an average $24.70 ($3,425,269)
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market sale Chief Medical Officer sold 10,000 shares at an average $22.93 ($229,286)
  12. 4 Open-market sale 10% owner sold 1,874,203 shares at $26.00 ($48,729,278)
  13. 4 Open-market sale Chief Development Officer sold 15,000 shares at an average $29.56 ($443,376)
  14. 4 Open-market sale Chief Medical Officer sold 10,000 shares at an average $29.54 ($295,390)
  15. 4 Open-market sale Chief Business Officer sold 19,900 shares at $35.03 ($697,097)
  16. 4 Open-market sale Vice President, Finance sold 26,654 shares at an average $35.02 ($933,371)
  17. 4 Open-market sale Chief Medical Officer sold 10,000 shares at $32.10 ($321,000)
  18. 4 Open-market sale Chief Business Officer sold 16,767 shares at an average $30.03 ($503,510)
  19. 4 Open-market sale Director sold 10,000 shares at $29.67 ($296,700)
  20. 4 Open-market sale Vice President, Finance sold 63,541 shares at $30.04 ($1,908,772)

Page 12 of 16 · 301 filings